| Literature DB >> 29686884 |
Michael S Rathleff1,2, Camilla R Rathleff2, Sinead Holden1, Kristian Thorborg3, Jens L Olesen1,4.
Abstract
BACKGROUND: Patellofemoral pain (PFP) is the most common knee condition among adolescents, with a prevalence of 6-7% resulting in reduced function and quality of life. Exercise therapy is recommended for treating PFP, but has only been tested in older adolescents (15-19 years). This pilot study aimed to investigate the adherence to, and clinical effects of, exercise and patient education in young adolescents (12-16 years), with PFP.Entities:
Year: 2018 PMID: 29686884 PMCID: PMC5899375 DOI: 10.1186/s40814-017-0227-7
Source DB: PubMed Journal: Pilot Feasibility Stud ISSN: 2055-5784
TIDieR checklist for reporting of interventions
| Intervention name | Why | What (materials and procedure) | Who provided | How? | Where did the intervention take place | When and how much? | Tailoring | Modification | How well? (fidelity and adherence) |
|---|---|---|---|---|---|---|---|---|---|
| Exercise therapy and patient education | This multimodal program has never been tested in young adolescents with PFP, only among 15–19 year olds with PFP. | One physiotherapist delivered the patient education, exercise therapy, and instructions on patellar taping. The exercise therapy was based on previous trials and consisted of a combination of supervised group training sessions and unsupervised home-based exercises. | Physiotherapist | Face to face | At the hospital | The unsupervised home exercises consisted of approximately 15 min of quadriceps and hip muscle retraining and stretching and were performed every day except for the days of supervised sessions. The supervised exercises were offered three times per week at the hospital for 13 weeks. Full description of intervention can be seen in this open access publication [ | To progressively match the exercise level to the performance level and pain levels of each participant, all exercises were available in multiple levels of difficulty. | All adolescents started with exercises at level 1 and progressed from there. The progression followed previously described rules. (1) Good quality of movement determined by the physiotherapist. ‘Good quality’ is defined as able to control hip, knee, and foot alignment during exercises with both extra-slow and slightly faster than normal movement. (2) Ability to perform the actual number of repetitions as defined in the training protocol. | Adherence to the supervised sessions was recorded as attendance. The adolescents participated in a median of 16 (IQR 5.5–25) supervised training session during the 13 weeks |
Participant characteristics
| Adolescents with PFP | |
|---|---|
| Age [years] | 14.6 (± 1.1) |
| Height [cm] | 167.0 (± 10.0) |
| Weight [kg] | 55.2 (± 9.0) |
| Gender (number of females) | 16 |
| BMI [kg/m2] | 19.5 (18.2–20.7)** |
| Pain duration [months] | 28.5 (24–36)** |
| Sports participation [times per week] | 4 (3–4.5)** |
| Regular use of pain killers (number of adolescents) | 11 |
The variables are presented as mean and standard deviation or median and inter-quartile range. BMI body mass index
**Presented as median and interquartile range
Fig. 1Adherence during the 3 months. In total, adolescents were offered to attend 39 supervised training sessions
Patient-reported outcome measures and physical activity level
| Baseline (± SD) | 3-month follow-up (± SD) | 6-month follow-up (± SD) | Mean change from baseline to 3 months (95% CI) | Mean change from 3 to 6 months (95% CI) | Mean change from baseline to 6 months (95% CI) | |
|---|---|---|---|---|---|---|
| KOOS pain | 71 (± 13) | 70 (± 16) | 76 (± 14) | 1 (− 8; 9) | 6 (− 1; 10) | 5 (− 2; 11) |
| KOOS symptom | 76 (± 11) | 77 (± 12) | 81 (± 11) | 0 (− 7; 6) | 4 (− 1; 7) | 5 (− 2; 11) |
| KOOS activities of daily living | 79 (± 13) | 82 (± 14) | 87 (± 10) | 2 (− 5; 9) | 5 (0; 9) | 7 (0; 13) |
| KOOS sport and recreation | 58 (± 19) | 62 (± 21) | 68 (± 21) | 4 (− 7; 14) | 6 (− 4;16) | 9 (1; 18) |
| KOOS quality of life | 54 (± 12) | 59 (± 21) | 59 (± 21) | 4 (− 4;11) | 0 (− 10;10) | 4 (− 4; 12) |
| Physical activity level (physical activity scale (METs)) | 45.0 (± 8.3) | 49.4 (± 10.7) | 55.4 (± 13.0) | 4.8 (− 1.8; 11.3) | 6.2 (− 1.1;13.6) | 10 (2; 19) |
| Health-related quality of life (EQ5D index**) | 0.75 (0.72–0.78) | 0.78 (0.72–0.82) | 0.82 (0.72;0.84) | |||
| Self-related health (EQ-VAS) | 76 (± 22) | 78 (± 15) | 78 (± 17) | − 1 (− 8; 9) | 0 (− 8; 8) | 1 (− 8; 6) |
| Worst pain last week (VAS* worst) | 62 (± 19) | 51 (± 27) | 48 (± 27) | − 10 (− 22; 3) | − 3 (− 14; 8) | − 13 (− 27; 1) |
| Pain during activity (VAS* activity) | 56 (± 19) | 37 (± 26) | 37 (± 22) | − 18 (− 30; 6) | − 1 (− 7; 5) | − 19 (− 30; − 8) |
*VAS visual analogue scale
**Reported as median and interquartile range
Isometric muscle strength at baseline and 3-month follow-up
| Baseline (±SD) | Follow-up at 3 months (±SD) | Difference (95% CI) | ||
|---|---|---|---|---|
| Knee extension (%BW) | 0.82 (± 0.21) | 0.84 (± 0.23) | 0.01 (− 0.04; 0.06) | 0.59 |
| Knee flexion (%BW) | 0.33 (± 0.07) | 0.33 (± 0.07) | 0.01(− 0.02; 0.03) | 0.63 |
| Hip abduction (%BW) | 0.26 (± 0.05) | 0.24 (± 0.05) | − 0.02 (− 0.03; 0.00) | 0.03 |
| Hip adduction (%BW) | 0.27 (± 0.07) | 0.24 (± 0.05) | − 0.03 (− 0.05; − 0.01) | 0.01 |
| Hip external rotation (%BW) | 0.21 (± 0.04) | 0.23 (± 0.05) | 0.01 (0.00; 0.02) | 0.05 |
| Hip internal rotation (%BW) | 0.32 (± 0.06) | 0.34 (± 0.07) | 0.02 (0.00; 0.04) | 0.09 |